Letter
Bisphosphonates in osteoporosis
Authors’ reply to Loukota and Musini and colleagues
Cite this as:
BMJ
2012;345:e5990
- Competing interests (ethics)
- Sociology
More topics 
Fewer topics
- Kenneth E Poole, university lecturer, honorary consultant rheumatologist1,
- Juliet E Compston, professor of bone medicine2
- 1Cambridge University Hospitals NHS Foundation Trust, Department of Medicine, Cambridge, UK
- 2Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke’s Hospital, Cambridge CB2 2QQ, UK
- jec1001{at}cam.ac.uk
Loukota refers to an “exponential increase” in the incidence of osteonecrosis of the jaw (ONJ) associated with bisphosphonate use.1 2 We are unaware of any evidence for this in patients treated with bisphosphonates for osteoporosis, either in the review quoted by Loukota or in the literature. The precautions set out in our paper are fully in line with those recommended …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
Social bookmarking